| Date Filed | Type | Description |
| 09/26/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $14.7, valued at
$147k
|
|
| 06/16/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 13,090 restricted stock units
@ $0
Granted 19,597 options to buy
@ $0 |
|
| 05/04/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,132 shares
@ $0
Granted 22,044 options to buy
@ $10.95, valued at
$241.4k
|
|
| 03/27/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Bought 50,000 shares
@ $0.8363, valued at
$41.8k
|
|
| 03/13/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Granted 48,290 shares
@ $1.17, valued at
$56.5k
Granted 106,837 restricted stock units
@ $0
Granted 125,489 options to buy
@ $1.17, valued at
$146.8k
|
|
| 02/24/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Exercised 61,576 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,024 restricted stock units
@ $0 |
|
| 10/04/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,138 restricted stock units
@ $0 |
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $8.38, valued at
$169.7k
|
|
| 06/09/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Bought 25,000 shares
@ $1.8075, valued at
$45.2k
|
|
| 05/27/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Granted 22,753 options to buy
@ $8.38, valued at
$190.7k
|
|
| 04/28/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 9,852 shares
@ $0
Granted 28,000 options to buy
@ $10.15, valued at
$284.2k
|
|
| 04/04/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,151 restricted stock units
@ $0 |
|
| 03/29/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Exercised 16,212 restricted stock units
@ $0 |
|
| 02/24/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Granted 27,832 shares
@ $2.03, valued at
$56.5k
Granted 61,576 restricted stock units
@ $0
Granted 83,189 options to buy
@ $2.03, valued at
$168.9k
|
|
| 01/04/2022 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 1,819 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 2,380 restricted stock units
@ $0 |
|
| 09/03/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $1.84, valued at
$9.2k
Exercised 10,000 options to buy
@ $4.64, valued at
$46.4k
Exercised 18,000 options to buy
@ $2.1, valued at
$37.8k
Exercised 50,000 options to buy
@ $4.56, valued at
$228k
|
|
| 07/02/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 2,048 restricted stock units
@ $0 |
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $24.46, valued at
$495.3k
|
|
| 06/09/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Granted 22,343 options to buy
@ $20.42, valued at
$456.2k
|
|
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Exercised 62,189 restricted stock units
@ $0 |
|
| 03/05/2021 |
4
| MITCHELL DEAN J (Director) has filed a Form 4 on PRECIGEN, INC.|
Txns:
| Exercised 2,968 options to buy
@ $5.69, valued at
$16.9k
|
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
3
| MITCHELL DEAN J (Director) has filed a Form 3 on Kinnate Biopharma Inc. |
| 10/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|